BioSig Technologies Stock Forecast, Price & News

BioSig Technologies (NASDAQ:BSGM) Frequently Asked Questions

What stocks does MarketBeat like better than BioSig Technologies?

Wall Street analysts have given BioSig Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but BioSig Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is BioSig Technologies' next earnings date?

BioSig Technologies is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for BioSig Technologies.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) announced its quarterly earnings results on Tuesday, August, 10th. The company reported ($0.24) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.26) by $0.02.
View BioSig Technologies' earnings history.

How has BioSig Technologies' stock been impacted by COVID-19 (Coronavirus)?

BioSig Technologies' stock was trading at $3.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BSGM stock has decreased by 4.5% and is now trading at $3.00.
View which stocks have been most impacted by COVID-19.

Who are BioSig Technologies' key executives?

BioSig Technologies' management team includes the following people:

• Kenneth L. Londoner, Executive Chairman & Chief Executive Officer (LinkedIn Profile)
• Steven Chaussy, Chief Financial Officer (LinkedIn Profile)
• Budimir S. Drakulic, Chief Scientist
• Barry Keenan, Vice President-Engineering
• Julie Stephenson, Vice President-Clinical Affairs

Who are some of BioSig Technologies' key competitors?

Some companies that are related to BioSig Technologies include Zynex (ZYXI), Edap Tms (EDAP), Second Sight Medical Products (EYES), Movano (MOVE), IRIDEX (IRIX), FONAR (FONR), Electromed (ELMD), electroCore (ECOR), ENDRA Life Sciences (NDRA), Soleno Therapeutics (SLNO), Yubo International Biotech (YBGJ), Fc Global Realty (FCRE), Helius Medical Technologies (HSDT), Viveve Medical (VIVE) and Precision Optics (PEYE).
View all of BSGM's competitors.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

What is BioSig Technologies' stock symbol?

BioSig Technologies trades on the NASDAQ under the ticker symbol "BSGM."

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (3.23%), InterOcean Capital Group LLC (2.76%), Renaissance Technologies LLC (0.94%), Geode Capital Management LLC (0.74%), Millennium Management LLC (0.67%) and Cambridge Investment Research Advisors Inc. (0.59%). Company insiders that own BioSig Technologies stock include Jeffrey F Odonnell, Jerome B Zeldis, Kenneth L Londoner, Kenneth L Londoner, Martha Pease, Samuel E Navarro and Steve Chaussy.
View institutional ownership trends for BioSig Technologies.

Which major investors are selling BioSig Technologies stock?

BSGM stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Northern Trust Corp, Vanguard Group Inc., Geode Capital Management LLC, Bank of America Corp DE, Saltoro Capital LP, Susquehanna International Group LLP, and Susquehanna Fundamental Investments LLC.
View insider buying and selling activity for BioSig Technologies or view top insider-selling stocks.

Which major investors are buying BioSig Technologies stock?

BSGM stock was purchased by a variety of institutional investors in the last quarter, including InterOcean Capital Group LLC, Renaissance Technologies LLC, Millennium Management LLC, Ergoteles LLC, Tibra Equities Europe Ltd, Kamunting Street Capital Management L.P., Cambridge Investment Research Advisors Inc., and Simplex Trading LLC. Company insiders that have bought BioSig Technologies stock in the last two years include Jerome B Zeldis, Kenneth L Londoner, Martha Pease, Samuel E Navarro, and Steve Chaussy.
View insider buying and selling activity for BioSig Technologies or or view top insider-buying stocks.

How do I buy shares of BioSig Technologies?

Shares of BSGM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioSig Technologies' stock price today?

One share of BSGM stock can currently be purchased for approximately $3.00.

How much money does BioSig Technologies make?

BioSig Technologies has a market capitalization of $104.77 million.

How many employees does BioSig Technologies have?

BioSig Technologies employs 49 workers across the globe.

What is BioSig Technologies' official website?

The official website for BioSig Technologies is www.biosig.com.

Where are BioSig Technologies' headquarters?

BioSig Technologies is headquartered at 54 WILTON ROAD, WESTPORT CT, 06880.

How can I contact BioSig Technologies?

BioSig Technologies' mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company can be reached via phone at (230) 409-5444 or via email at [email protected].